M&A Deal Summary |
|
---|---|
Date | 2023-11-10 |
Target | ViroStat |
Sector | Life Science |
Buyer(s) | Medix Biochemica |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1985 |
Sector | Life Science |
Employees | 220 |
Revenue | 55M EUR (2021) |
Medix Biochemica develops, manufactures, and markets critical raw materials including antibodies, antigens, and biologicals for IVD companies worldwide. Medix Biochemica was formed in 1985 and is based in Espoo, Finland.
DEAL STATS | # |
---|---|
Overall | 2 of 2 |
Sector (Life Science) | 2 of 2 |
Type (Add-on Acquisition) | 2 of 2 |
State (Maine) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2023) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-07-13 |
Diaclone
Besancon, France Diaclone provides expertise in the fields of inflammation, oncology, and immunology. The company offers best-in-class monoclonal antibodies, high-quality ELISA and ELISPOT kits as well as custom services ranging from immunoassay kit development to new antibody discovery using hybridoma and phage display technologies to a broad range of IVD, life science, and pharma customers. Diaclone was formed in 1986 and is based in Besancon, France. |
Buy | - |